US · Healthcare · Biotechnology
EPS came in at -0.45 against a street estimate of -0.33 — a miss of 36.4%.
Analysts rate CalciMedica, Inc. Common Stock a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $50.00.
| Fund | Stake |
|---|---|
| Squadron Capital Management LLC | 3.65% |
| Jane Street Group LLC | 0.52% |
| Vanguard Capital Management, LLC | 0.50% |
| Renaissance Technologies Corp | 0.38% |
| Geode Capital Management, LLC | 0.36% |
| 180 WEALTH ADVISORS, LLC | 0.24% |
| CAMBRIDGE Invest RESEARCH ADVISORS, INC. | 0.18% |
| Stonehage Fleming Financial Services Holdings Ltd | 0.16% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CalciMedica, Inc. Common Stock — free to start.
Google PlayApp StoreData updated 2026-09-18.